0001567619-20-004317.txt : 20200219 0001567619-20-004317.hdr.sgml : 20200219 20200219171405 ACCESSION NUMBER: 0001567619-20-004317 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200214 FILED AS OF DATE: 20200219 DATE AS OF CHANGE: 20200219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rao Madduri Ravin CENTRAL INDEX KEY: 0001792006 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 20631077 MAIL ADDRESS: STREET 1: C/O AEGLEA BIOTHERAPEUTICS, INC. STREET 2: 901 S. MOPAC EXPRESSWAY, #250 CITY: AUSTIN STATE: TX ZIP: 78746 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 805 LAS CIMAS PARKWAY STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc1.xml FORM 4 X0306 4 2020-02-14 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001792006 Rao Madduri Ravin C/O AEGLEA BIOTHERAPEUTICS, INC. 805 LAS CIMAS PARKWAY, SUITE 100 AUSTIN TX 78746 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 8.15 2020-02-14 4 A 0 25000 0.00 A 2030-02-13 Common Stock 25000 25000 D The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 14, 2020, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. /s/ Charles N. York II, by power of attorney 2020-02-19